Insider Transactions in Q4 2024 at Hologic Inc (HOLX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-1.44%
|
$6,570
$73.65 P/Share
|
|
Dec 09
2024
|
Martin D Madaus Director |
BUY
Grant, award, or other acquisition
|
Direct |
342
+50.0%
|
-
|
|
Dec 04
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,856
-47.06%
|
$1,889,056
$76.34 P/Share
|
|
Dec 04
2024
|
Essex D Mitchell Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,902
+11.47%
|
$1,282,512
$56.51 P/Share
|
|
Nov 14
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,860
-0.55%
|
$528,220
$77.54 P/Share
|
|
Nov 14
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-2.77%
|
$13,706
$77.54 P/Share
|
|
Nov 14
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-0.6%
|
$48,510
$77.54 P/Share
|
|
Nov 14
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-1.29%
|
$102,564
$77.54 P/Share
|
|
Nov 14
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-4.02%
|
$39,039
$77.54 P/Share
|
|
Nov 14
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-0.61%
|
$86,240
$77.54 P/Share
|
|
Nov 14
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,341
-4.29%
|
$103,257
$77.54 P/Share
|
|
Nov 14
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-0.97%
|
$8,470
$77.54 P/Share
|
|
Nov 14
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-1.65%
|
$30,030
$77.54 P/Share
|
|
Nov 11
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+3.1%
|
-
|
|
Nov 11
2024
|
Brandon Schnittker Div. President, GYN Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
2,834
+30.59%
|
-
|
|
Nov 11
2024
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+5.69%
|
-
|
|
Nov 11
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,447
+8.37%
|
-
|
|
Nov 11
2024
|
Jennifer M Schneiders President, Diag. Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+33.32%
|
-
|
|
Nov 11
2024
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,021
+26.07%
|
-
|
|
Nov 11
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,180
+9.41%
|
-
|
|
Nov 11
2024
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,298
+3.32%
|
-
|
|
Nov 11
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
4,723
+16.66%
|
-
|
|
Nov 08
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
68,447
-5.39%
|
$5,338,866
$78.76 P/Share
|
|
Nov 08
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
4,928
-4.78%
|
$384,384
$78.76 P/Share
|
|
Nov 08
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,598
-11.82%
|
$982,644
$78.76 P/Share
|
|
Nov 08
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.94%
|
$9,750
$78.76 P/Share
|
|
Nov 08
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,383
-17.81%
|
$341,874
$78.76 P/Share
|
|
Nov 08
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-1.83%
|
$14,820
$78.76 P/Share
|
|
Nov 08
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,299
-4.98%
|
$725,322
$78.76 P/Share
|
|
Nov 08
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
1,397
-6.88%
|
$108,966
$78.76 P/Share
|
|
Nov 07
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,214
-0.49%
|
$490,906
$79.29 P/Share
|
|
Nov 07
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-3.69%
|
$10,902
$79.29 P/Share
|
|
Nov 07
2024
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
601
-0.58%
|
$47,479
$79.29 P/Share
|
|
Nov 07
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,161
-1.08%
|
$91,719
$79.29 P/Share
|
|
Nov 07
2024
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-2.38%
|
$12,403
$79.29 P/Share
|
|
Nov 07
2024
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
422
-1.69%
|
$33,338
$79.29 P/Share
|
|
Nov 07
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-1.01%
|
$8,374
$79.29 P/Share
|
|
Nov 07
2024
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-0.32%
|
$46,768
$79.29 P/Share
|
|
Nov 07
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-1.67%
|
$27,176
$79.29 P/Share
|
|
Nov 05
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,710
+18.04%
|
-
|
|
Nov 05
2024
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
17,780
+14.64%
|
-
|
|
Nov 05
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
118,560
+8.5%
|
-
|
|
Nov 05
2024
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,854
+32.13%
|
-
|
|
Nov 05
2024
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+16.74%
|
-
|
|
Nov 05
2024
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,746
+9.98%
|
-
|